INTRODUCTIONIn oral cavity squamous cell carcinoma (SCC), several criteria allow estimation of survival outcomes, most importantly tumor classification and anatomic subsite. These factors also allow clinicians to determine treatment options, which have been well‐defined by nationally recognized guidelines. However, these decisions still involve significant clinical judgment, as the accuracy of clinical (presurgical) staging is limited. This is evident from previous studies finding that 35%‐45% of patients with oral cavity SCC present with occult nodal metastasis, the management of which remains controversial. Despite a growing body of literature that repeatedly redefines indications for specific treatment strategies, improvements in survival have been modest. The limitations of clinical staging may contribute to the relatively small improvements in survival rates of oral cavity SCC over the past 40 years compared with other head and neck cancers.Before surgery, the tumor size and extent are assessed by physical examination and imaging via computed tomography (CT), magnetic resonance imaging, or positron emission tomography, depending on the location and degree of disease. This disagreement between clinical and pathological staging of oral cavity SCC can be as high as 32%. Such stage discrepancy may result in significant clinical consequence. For the 23.7% of the patients who were pathologically
Head & Neck: Journal for the Sciences & Specialties of the Head and Neck – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera